Daniel Racalla
Physician Assistant · Traverse City, MINPI 1679292668
Payments from drug & device makers
Across 173 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$656
- AstraZeneca$452
- GSK$325
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$268
- Otsuka America Pharmaceutical, Inc.$267
- Exact Sciences$219
- plus $859 from 14 others
What the payments were for
- Food & beverage$3,046100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $656 |
| AstraZeneca | 22 | $452 |
| GSK | 21 | $325 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $268 |
| Otsuka America Pharmaceutical, Inc. | 15 | $267 |
| Exact Sciences | 10 | $219 |
| Astellas Pharma US Inc | 7 | $161 |
| Amgen(2 entities) | 8 | $144 |
| Verona Pharma, Inc. | 5 | $94 |
| Axsome Therapeutics, Inc. | 5 | $91 |
| Lilly USA, LLC | 5 | $79 |
| Hologic Sales And Service, LLC | 1 | $61 |
| Indivior Inc. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Novo Nordisk | 2 | $40 |
| Orexo US, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
How this compares
$3,046 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 114 | $86,642 |
| TrulicityDulaglutide | 68 | $73,020 |
| FarxigaDapagliflozin Propanediol | 36 | $37,262 |
| EliquisApixaban | 30 | $37,152 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 29 | $17,782 |
| JardianceEmpagliflozin | 12 | $11,307 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $6,523 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 164 | $3,984 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $3,129 |
| Paliperidone ErPaliperidone | 29 | $2,984 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 87 | $2,836 |
| Chlorpromazine Hcl | 11 | $2,730 |
| Omeprazole | 205 | $2,338 |
| Atorvastatin Calcium | 195 | $1,917 |
| Levothyroxine Sodium | 147 | $1,825 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $325 | $86,642114 claims |
| Lilly USA, LLCTrulicity | $79 | $73,02068 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $452 | $55,04465 claims |
| PfizerEliquis | $15 | $37,15230 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Traverse City
- Debra SwoverlandTraverse City$14K
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.